SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug Thatcher who wrote (776)3/16/1998 5:40:00 PM
From: seminole  Read Replies (1) of 1826
 
Doug

I look forward to your messages. Your experience with
this company will be a valuable addition to our
understanding of MOGN. Could you explain where this
company had problems in 1991-1993? It seems that these
failed expectations has lead to a very conservative management
style.

I followed the drug, MGI 114, to MOGN. I am just stupid/smart enough to believe this drug is the answer for cancer and just smart/stupid enough to bet the ranch on the company's balance sheet and income
statement. Phase II trials will determine how this should read.
"The good Lord was good to me. He gave me a strong body, a good
right arm, and a weak mind." Dizzy Dean

<<I bought 1700 shares for $10.50; thinking that the market had over-
reacted. I had a sell order in for all of it in September 1993 for $15.50, but it never quite got there and fell ever since. I still own the stock.>>

I would and I have taken tax losses on shares I bought at higher
prices ($5-6). You should consider replacing shares purchased at $10+
per share with shares purchased now at $5/sh. Now is still a good
time to lower your cost basis (I got mine down to about $4). Make
sure you understand the rules on wash sales (30+ days).

richard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News